A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans - PubMed (original) (raw)
. 2008 Oct 1;17(19):2997-3009.
doi: 10.1093/hmg/ddn198. Epub 2008 Jul 9.
Affiliations
- PMID: 18617532
- DOI: 10.1093/hmg/ddn198
A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans
Tomoki Kuwahara et al. Hum Mol Genet. 2008.
Abstract
Mutations or multiplications in alpha-synuclein gene cause familial forms of Parkinson disease or dementia with Lewy bodies (LB), and the deposition of wild-type alpha-synuclein as LB occurs as a hallmark lesion of these disorders, collectively referred to as synucleinopathies, implicating alpha-synuclein in the pathogenesis of synucleinopathy. To identify modifier genes of alpha-synuclein-induced neurotoxicity, we conducted an RNAi screen in transgenic C. elegans (Tg worms) that overexpress human alpha-synuclein in a pan-neuronal manner. To enhance the RNAi effect in neurons, we crossed alpha-synuclein Tg worms with an RNAi-enhanced mutant eri-1 strain. We tested RNAi of 1673 genes related to nervous system or synaptic functions, and identified 10 genes that, upon knockdown, caused severe growth/motor abnormalities selectively in alpha-synuclein Tg worms. Among these were four genes (i.e. apa-2, aps-2, eps-8 and rab-7) related to the endocytic pathway, including two subunits of AP-2 complex. Consistent with the results by RNAi, crossing alpha-synuclein Tg worms with an aps-2 mutant resulted in severe growth arrest and motor dysfunction. alpha-Synuclein Tg worms displayed a decreased touch sensitivity upon RNAi of genes involved in synaptic vesicle endocytosis, and they also showed impaired neuromuscular transmission, suggesting that overexpression of alpha-synuclein caused a failure in uptake or recycling of synaptic vesicles. Furthermore, knockdown of apa-2, an AP-2 subunit, caused an accumulation of phosphorylated alpha-synuclein in neuronal cell bodies, mimicking synucleinopathy. Collectively, these findings raise a novel pathogenic link between endocytic pathway and alpha-synuclein-induced neurotoxicity in synucleinopathy.
Similar articles
- Phosphorylation of α-synuclein protein at Ser-129 reduces neuronal dysfunction by lowering its membrane binding property in Caenorhabditis elegans.
Kuwahara T, Tonegawa R, Ito G, Mitani S, Iwatsubo T. Kuwahara T, et al. J Biol Chem. 2012 Mar 2;287(10):7098-109. doi: 10.1074/jbc.M111.237131. Epub 2012 Jan 9. J Biol Chem. 2012. PMID: 22232559 Free PMC article. - Identification of gene expression changes in transgenic C. elegans overexpressing human alpha-synuclein.
Vartiainen S, Pehkonen P, Lakso M, Nass R, Wong G. Vartiainen S, et al. Neurobiol Dis. 2006 Jun;22(3):477-86. doi: 10.1016/j.nbd.2005.12.021. Epub 2006 Apr 19. Neurobiol Dis. 2006. PMID: 16626960 - Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans.
Kuwahara T, Koyama A, Gengyo-Ando K, Masuda M, Kowa H, Tsunoda M, Mitani S, Iwatsubo T. Kuwahara T, et al. J Biol Chem. 2006 Jan 6;281(1):334-40. doi: 10.1074/jbc.M504860200. Epub 2005 Oct 31. J Biol Chem. 2006. PMID: 16260788 - alpha-Synucleinopathy models and human neuropathology: similarities and differences.
Kahle PJ. Kahle PJ. Acta Neuropathol. 2008 Jan;115(1):87-95. doi: 10.1007/s00401-007-0302-x. Epub 2007 Oct 12. Acta Neuropathol. 2008. PMID: 17932682 Review. - Alpha-synuclein and transgenic mouse models.
Fernagut PO, Chesselet MF. Fernagut PO, et al. Neurobiol Dis. 2004 Nov;17(2):123-30. doi: 10.1016/j.nbd.2004.07.001. Neurobiol Dis. 2004. PMID: 15474350 Review.
Cited by
- Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology.
Eisbach SE, Outeiro TF. Eisbach SE, et al. J Mol Med (Berl). 2013 Jun;91(6):693-703. doi: 10.1007/s00109-013-1038-9. Epub 2013 Apr 25. J Mol Med (Berl). 2013. PMID: 23616088 Review. - α-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis.
Scott D, Roy S. Scott D, et al. J Neurosci. 2012 Jul 25;32(30):10129-35. doi: 10.1523/JNEUROSCI.0535-12.2012. J Neurosci. 2012. PMID: 22836248 Free PMC article. - A monoclonal antibody toolkit for C. elegans.
Hadwiger G, Dour S, Arur S, Fox P, Nonet ML. Hadwiger G, et al. PLoS One. 2010 Apr 13;5(4):e10161. doi: 10.1371/journal.pone.0010161. PLoS One. 2010. PMID: 20405020 Free PMC article. - C. elegans in high-throughput drug discovery.
O'Reilly LP, Luke CJ, Perlmutter DH, Silverman GA, Pak SC. O'Reilly LP, et al. Adv Drug Deliv Rev. 2014 Apr;69-70:247-53. doi: 10.1016/j.addr.2013.12.001. Epub 2013 Dec 12. Adv Drug Deliv Rev. 2014. PMID: 24333896 Free PMC article. Review. - OFF-responses of interneurons optimize avoidance behaviors depending on stimulus strength via electrical synapses.
Hori S, Oda S, Suehiro Y, Iino Y, Mitani S. Hori S, et al. PLoS Genet. 2018 Jun 25;14(6):e1007477. doi: 10.1371/journal.pgen.1007477. eCollection 2018 Jun. PLoS Genet. 2018. PMID: 29939997 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous